|
|
| | 6,8,10,14-Eicosatetraenoic acid, 12-hydroxy-5-oxo-, (6Z,8E,10E,12R,14Z)- Basic information |
| Product Name: | 6,8,10,14-Eicosatetraenoic acid, 12-hydroxy-5-oxo-, (6Z,8E,10E,12R,14Z)- | | Synonyms: | 6,8,10,14-Eicosatetraenoic acid, 12-hydroxy-5-oxo-, (6Z,8E,10E,12R,14Z)-;5-oxo Leukotriene B4 | | CAS: | 195061-92-8 | | MF: | C20H30O4 | | MW: | 334.45 | | EINECS: | | | Product Categories: | | | Mol File: | 195061-92-8.mol |  |
| | 6,8,10,14-Eicosatetraenoic acid, 12-hydroxy-5-oxo-, (6Z,8E,10E,12R,14Z)- Chemical Properties |
| Boiling point | 546.1±50.0 °C(Predicted) | | density | 1.036±0.06 g/cm3(Predicted) | | solubility | Acetonitrile: 1 mg/ml | | pka | 4.59±0.10(Predicted) |
| | 6,8,10,14-Eicosatetraenoic acid, 12-hydroxy-5-oxo-, (6Z,8E,10E,12R,14Z)- Usage And Synthesis |
| Description | 5-oxo Leukotriene B4 (5-oxo LTB4) is a byproduct in the synthesis of 12-oxo LTB4 . | | Uses | 5-Oxo leukotriene B4 is a byproduct in the synthesis of 12-oxo LTB4 (HY-130497) with antiviral activity. 5-Oxo leukotriene B4 is promising for research of viral infections caused by human and animal enveloped RNA viruses[1]. | | References | [1] Jean Gosselin, et al. Agents with leukotriene B4-like antiviral (enveloped RNA) activities. US20060025479A1. 2009 January 06. |
| | 6,8,10,14-Eicosatetraenoic acid, 12-hydroxy-5-oxo-, (6Z,8E,10E,12R,14Z)- Preparation Products And Raw materials |
|